Boardman AP, Gutgarts V, Flynn J, Devlin SM, Goldman A, Tomas AA, Fein JA, Slingerland JB, Parascondola A, Lin RJ, Scordo M, Dahi PB, Giralt S, Palomba ML, Salles G, Nath K, Walji M, Corona M, Park JH, Shah GL, Perales M-A, Jaffer-Sathick I, Shouval R. Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapy. haematol [Internet]. 2020Sep.10 [cited 2025Jan.14];. Available from: https://haematologica.org/article/view/11835